Sustained-release naltrexone may slightly increase illicit opioid use and serious adverse events compared to opioid agonists, with uncertain effects on retention and acceptability. It may reduce ...

The Digital Marketing Officer is an exciting new role that reflects the strategic importance of digital marketing to Cochrane ...

El documentalista del Grupo Cochrane de Hipertensión (Cochrane Hypertension) buscó ensayos controlados aleatorizados en las siguientes bases de datos hasta abril de 2018 y de nuevo en marzo de 2020: ...

Hay pruebas de certeza moderada y baja que apoyan el uso de IGB-iv para el botulismo intestinal infantil. Un único ECA mostró que el uso de IGB-iv probablemente reduzca la duración de la ...

Level III sleep studies may result in little to no difference in clinical outcomes when compared to Level 1 sleep studies in people with suspected OSA. Level IV sleep studies may not increase ...

Title: Head of Technology Specifications: 6 months – F ixed term contract – Full time Salary: £63,000 per annum (will be ...

Due to a lack of robust evidence, the effects of melatonin on quality of life and sleep quality in people receiving treatment for cancer are unclear. Melatonin might not increase the risk of adverse ...

The included studies assessed antibiotics, bovine colostrum, Shiga toxin binding agent (Synsorb Pk) and monoclonal antibodies (Urtoxazumab) against Shiga toxin for secondary prevention of HUS in ...

The evidence does not currently support a clear benefit or harm for routine intravenous thrombolysis amongst people receiving endovascular thrombectomy. Amongst participants receiving endovascular ...

Acupuncture may reduce pain assessed with different scales during the procedure, with little to no difference in any harms, when compared to no intervention. The evidence is very uncertain about the ...